Migraine and suicidal ideation in adolescents aged 13 to 15 years

Neurology

Volumn 72, Issue 13, 2009, Pages 1146-1152

  Wang, Shuu Jiun ^a,b   Fuh, Jong Ling ^a,b   Juang, Kai Dih ^c   Lu, Shiang Ru ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Dr Soul Mental Health Center   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DEPRESSION; DEPRESSION INVENTORY; DISEASE ASSOCIATION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; PRIORITY JOURNAL; QUESTIONNAIRE; SUICIDAL IDEATION; TAIWAN; AGE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; INFORMATION PROCESSING; METHODOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK FACTOR; SUICIDE;

ADOLESCENT; AGE FACTORS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; RISK FACTORS; SUICIDE;

EID: 65249157016     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000345362.91734.b3     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. Homicide and suicide rates: National Violent Death Reporting System, six states, 2003. MMWR Morb Mortal Wkly Rep 2005;54:377-380.
2. Department of Health, Executive Yuan, Taiwan. Taiwan Area Main Causes of Death, 2005. Available at: http://www.doh.gov.tw/Statistic/index.htm. Accessed October 31, 2008.
3. US Public Health Service. Mental Health: A Report of the Surgeon General. 1989. Available at: http://www.mentalhealth.samhsa.gov/features/ surgeongeneralreport/toc.asp. Accessed October 31, 2008.
4. King RA, Gammon GD, Pfeffer CR, Cohen DJ. Suicide in childhood and adolescence. In: DSM-IV Sourcebook. Washington, DC: American Psychiatric Press; 1994:279-289.
5. Beck AT, Weishaar ME. Suicide risk assessment and prediction. Crisis 1990;11:22-30.
6. Hatcher-Kay C, King CA. Depression and suicide. Pediatr Rev 2003;24:363-371.
7. O'Carroll PW, Berman AL, Maris RW, Moscicki EK, Tanney BL, Silverman MM. Beyond the Tower of Babel: a nomenclature for suicidology. Suicide Life Threat Behav 1996;26:237-252.
8. Perez VW. The relationship between seriously considering, planning, and attempting suicide in the Youth Risk Behavior Survey. Suicide Life Threat Behav 2005;35:35-49.
9. Tang NKY, Crane C. Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links. Psych Med 2006;36:575-586.
10. Hitchcock LS, Ferrell BR, McCaffery M. The experience of chronic nonmalignant pain. J Pain Symptom Manage 1994;9:175-185.
11. Merikangas KR, Angst J, Isler H. Migraine and psychopathology: results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990;47:849-853.
12. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991;37:11-23.
13. Breslau N. Migraine, suicidal ideation, and suicide attempts. Neurology 1992;42:392-395.
14. Wang SJ, Juang KD, Fuh JL, Lu SR. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology 2007;68:1468-1473.
15. Lu SR, Fuh JL, Juang KD, Wang SJ. Migraine prevalence in adolescents aged 13-15: a student population-based study in Taiwan. Cephalalgia 2000;20:479-485.
16. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004;24 (suppl 1):1-160.
17. Huang CY, Hsu WY. A study of developing an adolescent depression inventory [in Chinese]. J Educ Psychol 2003; 26:167-190.
18. Hershey D, Powers SW, Vockell ALB, LeCates S, Kabbouche MA, Maynard MK. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology 2001;57:2034-2039.
19. Hershey AD, Powers SW, Vockell AL, LeCates SL, Segers A, Kabbouche MA. Development of a patient-based grading scale for PedMIDAS. Cephalalgia 2004;24:844-849.
20. Gutierrez PM, Osman A. Adolescent Suicide: An Integrated Approach to the Assessment of Risk and Protective Factors. DeKalb: Northern Illinois University Press; 2008.
21. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Office of Statistics and Programming. Web-based Injury Statistics Query and Reporting System (WISQARS). Available at: http://www.cdc.gov/ncipc/wisqars/. Accessed October 31, 2008.
22. Evans E, Hawton K, Rodham K, Deeks J. The prevalence of suicidal phenomena in adolescents: a systematic review of population-based studies. Suicide Life Threat Behav 2005;35:239-251.
23. Pelkonen M, Marttunen M. Child and adolescent suicide: epidemiology, risk factors, and approaches to prevention. Paediatr Drugs 2003;5:243-265.
24. Lewinsohn PM, Rohde P, Seeley JR. Adolescent suicidal ideation and attempts: prevalence, risk factors, and clinical implications. Clin Psychol Sci Prac 1996;3:25-46.
25. Reinherz HZ, Tanner JL, Berger SR, et al. Adolescent suicidal ideation as predictive of psychopathology, suicidal behavior, and compromised functioning at age 30. Am J Psychiatry 2006;163:1226-1232.
26. American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. J Am Acad Child Adolesc Psychiatry 2001;40 (suppl 7):24S-51S.
27. Pelkonen M, Marttunen M. Child and adolescent suicide: epidemiology, risk factors, and approaches to prevention. Pediatric Drugs 2003;5:243-265.
28. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA 2004;292:338-343.
29. US Food and Drug Administration. Suicidality and Antiepileptic Drugs. Available at: http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. Accessed October 31, 2008.
30. Post RM, Silberstein SD. Shared mechanisms in affective illness, epilepsy, and migraine. Neurology 1994;44 (suppl 7):S37-S47.
31. Pandey GN, Dwivedi Y, Rizavi HS, et al. Higher expression of serotonin 5-HT2A receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002; 159:419-429.
32. Nagata E, Shibata M, Hamada J, et al. Plasma 5-hydroxytryptamine (5-HT) in migraine during an attackfree period. Headache 2006;46:592-596.
33. Purselle DC, Nemeroff CB. Serotonin transporter: a potential substrate in the biology of suicide. Neuropsychopharmacology 2003;28:613-619.
34. Marziniak M, Mossner R, Schmitt A, Lesch KP, Sommer C. A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 2005;64: 157-159.
35. Borroni B, Brambilla C, Liberini P, et al. Functional serotonin 5-HTTLPR polymorphism is a risk factor for migraine with aura. J Headache Pain 2005;6:182-184.
36. Du L, Bakish D, Lapierre YD, Ravindran AV, Hrdina PD. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet 2000;96:56-60.
37. Srikiatkhachorn A, Govitrapong P, Limthavon C. Upregulation of 5-HT2 serotonin receptor: a possible mechanism of transformed migraine. Headache 1994;34:8-11.
38. Kotani K, Shimomura T, Shimomura F, Ikawa S, Nanba E. A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 2002;42:893-895.
39. Druss B, Pincus H. Suicidal ideation and suicide attempts in general medical illnesses. Arch Intern Med 2000;160: 1522-1526.
40. Wang SJ, Fuh JL, Lu SR, Juang KD. Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 2006;66:193-197.